Laraway Financial Advisors’s Merck MRK Stock Holding History

Laraway Financial Advisors’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$351K	Buy	2,729 +6	+0.2%	+$702	0.21%	107
2026 Q1	$328K	Sell	2,723 -720	-21%	-$83.1K	0.23%	99
2025 Q4	$362K	Hold	3,443	–	–	0.24%	97
2025 Q3	$289K	Buy	3,443 +301	+10%	+$24.8K	0.2%	108
2025 Q2	$249K	Hold	3,142	–	–	0.19%	110
2025 Q1	$282K	Sell	3,142 -250	-7%	-$23.3K	0.22%	98
2024 Q4	$337K	Hold	3,392	–	–	0.26%	87
2024 Q3	$385K	Sell	3,392 -50	-1%	-$5.94K	0.31%	75
2024 Q2	$426K	Hold	3,442	–	–	0.36%	69
2024 Q1	$454K	Hold	3,442	–	–	0.4%	71
2023 Q4	$375K	Buy	3,442 +76	+2%	+$7.89K	0.36%	74
2023 Q3	$347K	Hold	3,366	–	–	0.36%	73
2023 Q2	$388K	Sell	3,366 -250	-7%	-$28.4K	0.38%	72
2023 Q1	$385K	Sell	3,616 -400	-10%	-$43.2K	0.39%	79
2022 Q4	$446K	Sell	4,016 -4	-0.1%	-$409	0.47%	68
2022 Q3	$346K	Sell	4,020 -20	-0.5%	-$1.78K	0.39%	75
2022 Q2	$368K	Sell	4,040 -100	-2%	-$8.87K	0.39%	78
2022 Q1	$340K	Sell	4,140 -20	-0.5%	-$1.58K	0.31%	85
2021 Q4	$319K	Buy	+4,160	New	+$331K	0.28%	91

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Laraway Financial Advisors's MRK Position: Q2 2026 in Review

Laraway Financial Advisors increased its Merck (MRK) stake by 0.22% in Q2 2026, buying an estimated $702 and bringing the position to 2,729 shares worth $351K. The position accounts for 0.21% of the portfolio, ranked #107.

Laraway Financial Advisors first reported a position in MRK in Q4 2021 and has held it in 19 quarters since. The position peaked at $454K in Q1 2024. 3,842 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Laraway Financial Advisors held 2,729 shares of Merck worth $351K as of Q2 2026.
Laraway Financial Advisors bought 6 Merck shares in Q2 2026, an estimated $702.
Merck made up 0.21% of Laraway Financial Advisors's portfolio in Q2 2026, its #107 holding.
Laraway Financial Advisors first reported a position in Merck in Q4 2021 and has held it in 19 quarters since.
Laraway Financial Advisors's Merck position peaked at $454K in Q1 2024.
3,842 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Laraway Financial Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.